MnM_logo_TM_JPG.JPG
Nucleic Acid Isolation and Purification Market is Expected to Reach $9.2 Billion | MarketsandMarkets.
June 19, 2023 09:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, June 19, 2023 (GLOBE NEWSWIRE) -- The nucleic acid isolation and purification industry is poised for remarkable growth and innovation in the near future. With the increasing demand for...
22157.jpg
Global Messenger RNA (mRNA) Vaccines & Therapeutics Market Research Report 2022 Featuring Pfizer, GSK, Daiichi Sankyo, Intellia Therapeutics, Moderna, CureVac, Arcturus Therapeutics, & BioNTech
January 05, 2023 04:03 ET | Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Messenger RNA (mRNA) Vaccines & Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity...
22157.jpg
Global Exosome-Mediated Drug Delivery Technology Market Research Report 2022: Exosomes Are Promising Delivery Carriers for Advanced Therapeutics
November 07, 2022 07:48 ET | Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Growth Opportunities for Exosome-Mediated Drug Delivery" report has been added to ResearchAndMarkets.com's offering. This research...
Global RNA Based Therapeutics Market
Outlook on the RNA Based Therapeutic Global Market to 2030 - Multifactorial Disease Targeting Presents Opportunities
April 28, 2022 06:43 ET | Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "RNA Based Therapeutic Market by Disease Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
22157.jpg
Global RNA Stabilization & Delivery Technology Advances Market Report 2021: LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years
February 15, 2022 05:43 ET | Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Technological Advances in RNA Stabilization & Delivery" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a rapidly...
22157.jpg
North America miRNA Sequencing and Assay Market Report 2021-2027: Widening Range of MicroRNA Applications & Rise in Funding for Genomics Research
September 22, 2021 07:28 ET | Research and Markets
Dublin, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The "North America miRNA Sequencing and Assay Market 2021-2027 by Product, Technology, and End User" report has been added to ResearchAndMarkets.com's...
22157.jpg
Europe $144 Mn miRNA Sequencing and Assay Market to 2027: Development and Launch of Innovative Products Gaining Momentum
September 21, 2021 04:28 ET | Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Europe miRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product, Technology, and End User" report has...
TBIO.jpg
Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development
August 03, 2021 01:00 ET | Translate Bio, Inc.
-- Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas -- -- Fast tracks establishment of Sanofi’s recently announced mRNA Center...
TBIO.jpg
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
June 22, 2021 01:00 ET | Translate Bio, Inc.
-- Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise -- -- Positive preclinical safety and immunogenicity data...
TBIO.jpg
Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
June 07, 2021 07:30 ET | Translate Bio, Inc.
-- $50 million milestone payment to be received this month for successful manufacturing, release, and delivery of clinical drug product to support influenza mRNA vaccine clinical trial anticipated to...